Strisun Drugs Llp

Strisun Drugs Llp - healthcare in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
LLPIN AAS-6614 Incorporated 19 June 2020 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Limited Liability Partnership healthcare
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
*****
In full report
Net profit · Latest
*****
In full report
Contribution obligation
₹1 Lakh
As per LLP agreement
Paid-up contribution
-
Contribution received
Open charges
₹8 Cr
Satisfied ₹2 Cr
Company age
6 yrs
Est. 2020
Last financials
Mar 2025
Balance sheet date

About Strisun Drugs Llp

Data last updated: 16 February 2026

Strisun Drugs Llp is a limited liability partnership company based in Mumbai, Maharashtra, India. It specialises in medical and laboratory equipment, a part of the broader healthcare sector. Incorporated on 19 June 2020, the LLP has been in operation for over 6 years.

Registered with ROC Mumbai under LLPIN AAS-6614.

Capital: a total obligation of contribution of ₹1 Lakh. It is led by designated partners Abu Saria and Dhruv Kirit Gala.

Accounts filed on 31 March 2025. Office: G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101.

As per MCA filings, the LLP has open charges of ₹8 Cr and satisfied charges of ₹2 Cr on record.

Company Details of Strisun Drugs Llp
LLPIN AAS-6614
Incorporation Date 19 June 2020
Total Obligation of Contribution ₹1 Lakh
ROC Mumbai
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Abu Saria Designated Partner Dhruv Kirit Gala Designated Partner
Contact Details
  • Email
    **************
  • Telephone
    **************
  • Website
    **************
  • Social Media
    **************
  • Registered Address
    G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali (East), Mumbai, Maharashtra, India – 400101
  • Industry
    Healthcare, Medical & Laboratory Equipment
Company report
Strisun Drugs Llp - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Strisun Drugs Llp report

Financials, compliance, directors, charges, ownership and filings for Strisun Drugs Llp in one report.

10-year financials Directors & ownership Charges & compliance

Designated Partners of Strisun Drugs Llp

Strisun Drugs Llp is governed by 2 designated partners who oversee the company's operations and strategic decisions.

Current Designated Partners
Name Designation Appointment Date Tenure Status
Abu Saria
Also directs: Alimi Exports Llp, Saria & Gala Ventures Llp, Strisun Foods Private Limited
Designated Partner 19 Jun 2020 6 Years 0 Months Current
Dhruv Kirit Gala
Also directs: Saria & Gala Ventures Llp, Strisun Foods Private Limited
Designated Partner 19 Jun 2020 6 Years 0 Months Current
View all designated partners

Financials of Strisun Drugs Llp FY 2025 filings available

Metrics
*****
*****
*****
*****
*****
Revenue
Revenue from Operations
*****
*****
*****
*****
*****
Revenue Growth %
*****
*****
*****
*****
*****
Other Income
*****
*****
*****
*****
*****
Total Revenue
*****
*****
*****
*****
*****
Expenses
Total Expenses
*****
*****
*****
*****
*****
Raw Material Cost
*****
*****
*****
*****
*****
Change in Inventory FG
*****
*****
*****
*****
*****
Change in Inventory WIP
*****
*****
*****
*****
*****
Purchase of Traded Goods
*****
*****
*****
*****
*****
Employee Cost
*****
*****
*****
*****
*****
Managerial Remuneration
*****
*****
*****
*****
*****
Audit Fees
*****
*****
*****
*****
*****
Insurance
*****
*****
*****
*****
*****
Power & Fuel
*****
*****
*****
*****
*****
Interest
*****
*****
*****
*****
*****
Depreciation
*****
*****
*****
*****
*****
Other Expenses
*****
*****
*****
*****
*****
Profitability
EBITDA (Operating Profit)
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
Exceptional Items
*****
*****
*****
*****
*****
Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Exceptional & Extraordinary Items
*****
*****
*****
*****
*****
Profit Before Tax
*****
*****
*****
*****
*****
Tax & Net Profit
Tax Expense
*****
*****
*****
*****
*****
Current Tax
*****
*****
*****
*****
*****
Deferred Tax
*****
*****
*****
*****
*****
Profit from Discontinued Operations
*****
*****
*****
*****
*****
Tax on Discontinued Operations
*****
*****
*****
*****
*****
Profit
*****
*****
*****
*****
*****
Net Margin %
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Shareholders' Funds
Total Shareholders' Funds
*****
*****
*****
*****
*****
Equity Capital
*****
*****
*****
*****
*****
Reserves & Surplus
*****
*****
*****
*****
*****
Money Against Warrants
*****
*****
*****
*****
*****
Other Equity
*****
*****
*****
*****
*****
Non-Current Liabilities
Total Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Borrowings
*****
*****
*****
*****
*****
Deferred Tax Liabilities
*****
*****
*****
*****
*****
Other Non-Current Liabilities
*****
*****
*****
*****
*****
Long-Term Provisions
*****
*****
*****
*****
*****
Current Liabilities
Total Current Liabilities
*****
*****
*****
*****
*****
Short-Term Borrowings
*****
*****
*****
*****
*****
Trade Payables
*****
*****
*****
*****
*****
Other Current Liabilities
*****
*****
*****
*****
*****
Short-Term Provisions
*****
*****
*****
*****
*****
Total Equity & Liabilities
*****
*****
*****
*****
*****
Non-Current Assets
Non-Current Assets
*****
*****
*****
*****
*****
Tangible Assets
*****
*****
*****
*****
*****
Intangible Assets
*****
*****
*****
*****
*****
Capital WIP
*****
*****
*****
*****
*****
Intangibles Under Dev
*****
*****
*****
*****
*****
Investments
*****
*****
*****
*****
*****
Deferred Tax Assets
*****
*****
*****
*****
*****
LT Loans & Advances
*****
*****
*****
*****
*****
Other Non-Current Assets
*****
*****
*****
*****
*****
Current Assets
Current Assets
*****
*****
*****
*****
*****
Current Investments
*****
*****
*****
*****
*****
Inventories
*****
*****
*****
*****
*****
Trade Receivables
*****
*****
*****
*****
*****
Cash & Bank Balance
*****
*****
*****
*****
*****
ST Loans & Advances
*****
*****
*****
*****
*****
Other Current Assets
*****
*****
*****
*****
*****
Total Assets
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Cash from Operating Activities (CFO)
Profit Before Tax
*****
*****
*****
*****
*****
Non-Cash Adjustments
*****
*****
*****
*****
*****
+ Interest Expense
*****
*****
*****
*****
*****
+ Depreciation
*****
*****
*****
*****
*****
+/- Unrealized Forex
*****
*****
*****
*****
*****
- Dividend Income
*****
*****
*****
*****
*****
- Interest Income
*****
*****
*****
*****
*****
+/- Other Non-Cash Items
*****
*****
*****
*****
*****
Changes in Working Capital
*****
*****
*****
*****
*****
+/- Inventory
*****
*****
*****
*****
*****
+/- Debtors
*****
*****
*****
*****
*****
+/- Creditors
*****
*****
*****
*****
*****
Reconciliation Adjustments
*****
*****
*****
*****
*****
Cash Generated from Operations
*****
*****
*****
*****
*****
Income Taxes Paid
*****
*****
*****
*****
*****
Net CFO (Cash from Operations)
*****
*****
*****
*****
*****
Cash from Investing Activities (CFI)
Acquisitions & Disposals
*****
*****
*****
*****
*****
Disposal of Subsidiaries
*****
*****
*****
*****
*****
Acquisition of Subsidiaries
*****
*****
*****
*****
*****
Capex
*****
*****
*****
*****
*****
Purchase of Fixed Assets
*****
*****
*****
*****
*****
Sale of Fixed Assets
*****
*****
*****
*****
*****
Other Investing Cash Flows
*****
*****
*****
*****
*****
Net CFI (Cash from Investing)
*****
*****
*****
*****
*****
Cash from Financing Activities (CFF)
Equity Issuance
*****
*****
*****
*****
*****
Debt Raised
*****
*****
*****
*****
*****
Debt Repaid
*****
*****
*****
*****
*****
Dividends Paid
*****
*****
*****
*****
*****
Interest Paid
*****
*****
*****
*****
*****
Net CFF (Cash from Financing)
*****
*****
*****
*****
*****
Net Cash Position
Net Change in Cash (Pre-Forex)
*****
*****
*****
*****
*****
Closing Cash & Equivalents
*****
*****
*****
*****
*****
Metrics
*****
*****
*****
*****
*****
Liquidity
Current Ratio
*****
*****
*****
*****
*****
Quick Ratio
*****
*****
*****
*****
*****
Cash Ratio
*****
*****
*****
*****
*****
Efficiency
Inventory Days
*****
*****
*****
*****
*****
Debtor Days
*****
*****
*****
*****
*****
Creditor Days
*****
*****
*****
*****
*****
Cash Conversion Cycle
*****
*****
*****
*****
*****
Asset Turnover
*****
*****
*****
*****
*****
Profitability
Net Profit Margin %
*****
*****
*****
*****
*****
Operating Margin %
*****
*****
*****
*****
*****
ROE %
*****
*****
*****
*****
*****
ROCE %
*****
*****
*****
*****
*****
Net Worth Margin %
*****
*****
*****
*****
*****
Growth
Revenue Growth %
*****
*****
*****
*****
*****
Leverage
Equity Multiplier
*****
*****
*****
*****
*****
Debt / EBITDA
*****
*****
*****
*****
*****
Solvency
D/E Ratio
*****
*****
*****
*****
*****
ICR
*****
*****
*****
*****
*****
Unlock Complete Financial History (FY 2015 – Latest)
Standalone & Consolidated - Income Statement, Balance Sheet, Cash Flow, Financial Ratios and Growth Trends with 10+ years of line-item data.
10+ years of data Line-item breakdown Balance Sheet detail Cash Flow analysis 20+ ratios & metrics Downloadable PDF

Charges & Borrowings of Strisun Drugs Llp

Open charges
₹8 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Icici Bank Limited₹8.00 Cr
Latest charge details
DateLenderAmountStatus
24 Mar 2025 Icici Bank Limited ₹8 Cr Open
29 Dec 2022 Idfc First Bank Limited ₹2 Cr Satisfied

Total charge records: 2 View all charges

Employees and EPFO Compliance at Strisun Drugs Llp

View historical data on people associated with Strisun Drugs Llp, including employment history and EPFO contributions.

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Strisun Drugs Llp

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Strisun Drugs Llp

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Strisun Drugs Llp

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Strisun Drugs Llp

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Strisun Drugs Llp

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Strisun Drugs Llp

MSME Payment Delays by Strisun Drugs Llp

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Strisun Drugs Llp

Subsidiaries & Group Companies of Strisun Drugs Llp

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Strisun Drugs Llp with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Strisun Drugs Llp

MCA Filings & Documents of Strisun Drugs Llp

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Strisun Drugs Llp

Charges
06 Jun 2025
A charge registered on 29 Dec 2022 via Charge ID 100665851 with Idfc First Bank Limited was fully satisfied on 06 Jun 2025.
Activity
31 Mar 2025
Strisun Drugs Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Activity
31 Mar 2025
Strisun Drugs Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
24 Mar 2025
A charge with Icici Bank Limited amounted to Rs. 800.00 Lakh with Charge ID 101086421 was registered on 24 Mar 2025.
Charges
29 Dec 2022
A charge with Idfc First Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100665851 was registered on 29 Dec 2022.
Directors
19 Jun 2020
Abu Saria was appointed as a Designated Partner on 19 Jun 2020 & has been associated with this company since 6 years 21 days.

Frequently Asked Questions about Strisun Drugs Llp

Strisun Drugs Llp is an active limited liability partnership in the healthcare sector based in Mumbai, Maharashtra, India. It was incorporated on 19 June 2020 (6+ years old) and is registered under LLPIN AAS-6614.

The current designated partners of Strisun Drugs Llp are:

The primary industry of Strisun Drugs Llp is healthcare. The LLP specifically operates in medical and laboratory equipment. The LLP is currently active in this sector.

Strisun Drugs Llp can be reached at the registered office: G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali East, Mumbai, Maharashtra, India – 400101.

The total obligation of contribution is ₹1 Lakh.

The LLP has its registered office at G 1701 Octacrest Lokhandwala Township Akurli Road Kandivali East, Mumbai, Maharashtra, India – 400101.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available